植物化学物质在调节PD-1/PD-L1和免疫检查点阻塞疗法中的作用
Qi Zhang1, Chenying Yang2, Xingsu Gao1
1Department of Public Health, School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Phytotherapy research : PTR
|December 5, 2023
概括
植物化学物质,来自植物的天然化合物,通过向PD-1/PD-L1.1.等免疫检查点来增强癌症免疫疗法. 将植物化学物质与免疫检查点抑制剂结合起来,可以增强抗瘤效应和T细胞透.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫检查点封锁是一种关键的癌症治疗方法.
- 结合疗法旨在提高疗效和减少副作用.
- 植物化学物质表现出抗癌性质,并调节瘤微环境.
研究的目的:
- 审查免疫检查点分子作为癌症治疗点.
- 评估植物化学物质对PD-1/PD-L1免疫检查点的影响.
- 为了记录植物化学品和免疫检查点抑制剂的组合作用.
主要方法:
- 临床和临床前研究的文献综述.
- 对植物化学物质对癌细胞系和体内模型的影响的分析.
- 检查植物化学物质对瘤微环境和免疫细胞的调节.
主要成果:
- 植物化学物质表现出抗增殖,益,抗迁移和抗血管效应.
- 植物化学物质降低编程细胞死亡-1 (PD-L1) 的表达.
- 结合植物化学物质和PD-1抑制剂可以增强瘤生长抑制和T细胞透.
结论:
- 植物化学物质是增强癌症免疫疗法的有希望的策略.
- 用植物化学品和抑制剂向PD-1/PD-L1提供了协同作用的抗癌效应.
- 对于各种恶性瘤,需要对基于植物化学的组合疗法进行进一步的研究.
相关概念视频
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
Inflammatory Response
2.0K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K


